MicroRNA ‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)

ConclusionsIntegrating biomarkers across different body fluids would synergistically improve the early detection of NSCLC.Key points Lung cancer is a heterogeneous disease and develops from complex aberrations. Integrating sputum and plasma miRNAs has higher accuracy than when they are used alone
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research